Market Closed -
Nasdaq
02:00:01 17/05/2024 am IST
|
5-day change
|
1st Jan Change
|
2.51
USD
|
-2.71%
|
|
+16.74%
|
+24.88%
|
Fiscal Period: September |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
53.72
|
12.29
|
3.464
|
Enterprise Value (EV)
1 |
36.25
|
-2.635
|
-9.558
|
P/E ratio
|
4.14
x
|
-1.41
x
|
-0.56
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.12
x
|
0.31
x
|
0.11
x
|
EV / Revenue
|
0.76
x
|
-0.07
x
|
-0.3
x
|
EV / EBITDA
|
2.58
x
|
0.38
x
|
3.17
x
|
EV / FCF
|
-19,47,095
x
|
-6,61,467
x
|
-60,05,029
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
Price to Book
|
0.91
x
|
0.26
x
|
0.09
x
|
Nbr of stocks (in thousands)
|
3,625
|
3,625
|
3,646
|
Reference price
2 |
14.82
|
3.390
|
0.9500
|
Announcement Date
|
31/01/22
|
10/02/23
|
30/01/24
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
28.51
|
33.23
|
30.7
|
47.98
|
40.14
|
32.31
|
EBITDA
1 |
10.11
|
10.43
|
10.66
|
14.04
|
-6.905
|
-3.018
|
EBIT
1 |
9.656
|
10.01
|
10.25
|
13.59
|
-7.439
|
-3.527
|
Operating Margin
|
33.87%
|
30.14%
|
33.39%
|
28.32%
|
-18.53%
|
-10.92%
|
Earnings before Tax (EBT)
1 |
9.518
|
9.653
|
10.1
|
13.68
|
-7.984
|
-3.85
|
Net income
1 |
7.603
|
7.551
|
7.558
|
11.32
|
-8.737
|
-6.163
|
Net margin
|
26.66%
|
22.73%
|
24.62%
|
23.59%
|
-21.76%
|
-19.08%
|
EPS
2 |
2.851
|
2.832
|
2.834
|
3.578
|
-2.410
|
-1.700
|
Free Cash Flow
|
-
|
0.3751
|
4.922
|
-18.62
|
3.984
|
1.592
|
FCF margin
|
-
|
1.13%
|
16.03%
|
-38.8%
|
9.92%
|
4.93%
|
FCF Conversion (EBITDA)
|
-
|
3.59%
|
46.17%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
4.97%
|
65.12%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/08/20
|
17/08/20
|
24/02/21
|
31/01/22
|
10/02/23
|
30/01/24
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
3.57
|
0.66
|
7.41
|
17.5
|
14.9
|
13
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
0.38
|
4.92
|
-18.6
|
3.98
|
1.59
|
ROE (net income / shareholders' equity)
|
-
|
68.4%
|
45.5%
|
28.4%
|
-16.6%
|
-14.3%
|
ROA (Net income/ Total Assets)
|
-
|
27.3%
|
27.5%
|
17.2%
|
-7.17%
|
-3.91%
|
Assets
1 |
-
|
27.7
|
27.51
|
65.94
|
121.8
|
157.7
|
Book Value Per Share
2 |
3.630
|
4.640
|
7.800
|
16.30
|
12.80
|
10.90
|
Cash Flow per Share
2 |
2.320
|
1.190
|
3.770
|
2.230
|
1.580
|
1.460
|
Capex
1 |
0.15
|
0.09
|
0.05
|
13.5
|
0.09
|
0.04
|
Capex / Sales
|
0.51%
|
0.26%
|
0.17%
|
28.2%
|
0.23%
|
0.14%
|
Announcement Date
|
17/08/20
|
17/08/20
|
24/02/21
|
31/01/22
|
10/02/23
|
30/01/24
|
|
1st Jan change
|
Capi.
|
---|
| +24.88% | 9.1M | | +42.64% | 6.28B | | -15.52% | 4.51B | | +8.35% | 3.35B | | -11.10% | 3.13B | | -4.12% | 2.47B | | +46.46% | 1.96B | | -7.97% | 1.68B | | -1.07% | 1.63B | | -11.56% | 1.56B |
Alternative Medicine
|